happy to be called naive and ultimately be wrong - but I'd be siding with a combo of financing through tax credits, further info sharing agreements and if needed a soph placement. Not sure they'll go to retail again.
Given the tax credits available are surplus to expenses for the quarter, and with an anticipated time frame of the program being completed within the quarter, I think Neil and RC and co will be out in front of the market with strong optimism and "investment opportunities" if the results are in line with what we have seen so far.
- Forums
- ASX - By Stock
- EXR
- Ann: Quarterly Activities Report and Appendix 5B Mar 2024
Ann: Quarterly Activities Report and Appendix 5B Mar 2024, page-5
Featured News
Add EXR (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $59.84M |
Open | High | Low | Value | Volume |
5.0¢ | 5.1¢ | 4.9¢ | $131.0K | 2.642M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 116832 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 467062 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 116832 | 0.049 |
8 | 697930 | 0.048 |
5 | 626615 | 0.047 |
1 | 21630 | 0.046 |
11 | 733977 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 467062 | 3 |
0.051 | 705635 | 3 |
0.052 | 304753 | 4 |
0.053 | 193200 | 3 |
0.054 | 107750 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
EXR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online